Clinical meaning
Necrotizing fasciitis is a rapidly progressive, life-threatening deep soft tissue infection that spreads along fascial planes, destroying subcutaneous tissue, fascia, and potentially muscle, with mortality rates of 20-40% even with optimal treatment. The infection is classified by microbiology: Type I (polymicrobial, most common) involves a synergistic mixture of aerobic and anaerobic organisms (streptococci, staphylococci, Enterobacteriaceae, Bacteroides, Clostridium) typically occurring in immunocompromised or post-surgical patients; Type II (monomicrobial) is caused by Group A Streptococcus (Streptococcus pyogenes) alone, often in previously healthy individuals, and is associated with streptococcal toxic shock syndrome from superantigen production (SPE-A, SPE-B). The pathophysiology involves bacterial enzymes (hyaluronidases, lipases, streptokinases) that dissolve fascial barriers, enabling rapid lateral spread. Thrombosis of nutrient blood vessels within the fascial planes causes ischemic necrosis, creating an anaerobic environment that further promotes bacterial proliferation. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score uses six laboratory parameters — CRP (greater than 150 mg/L = 4 points), WBC (greater than 25,000 = 2 points), hemoglobin (less than 11 g/dL = 2 points), sodium (less than 135 mEq/L = 2 points), creatinine (greater than 1.6 mg/dL = 2 points), and glucose (greater than 180 mg/dL = 1 point) — to risk-stratify patients. A score of 6 or higher has a positive predictive value of approximately 92% for NSTI, but a low score does NOT rule out the diagnosis; clinical suspicion must always supersede scoring tools. Emergent surgical debridement is the single most important intervention: all necrotic tissue is excised until viable, bleeding tissue is encountered. The wound is left open for serial exploration and debridement every 24-48 hours. Time to surgery is the strongest modifiable determinant of mortality — each hour of delay worsens outcomes.